High Quality Undervalued Stocks

Results

258

61 new
This selection of undervalued companies are the market's hidden engines of wealth. Not only do they combine good cash flows with and a solid balance sheet, but they are also poised for a breakout.

258 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
MRK
US$129.79-0.5%66.1%US$322.0bUS$135.1935.921.2%2.6%Pharmaceuticals & Biotech
PLTR
US$122.26-0.5%-20.7%US$293.1bUS$182.20128.531.9%n/aSoftware
STX
US$851.68-0.001%450.1%US$193.2bUS$1,106.0960.730.1%0.3%Tech
AIR
€204.00-0.2%15.9%€161.5b€222.9127.214.7%1.6%Capital Goods
WDC
US$533.04-4.5%577.4%US$159.3bUS$655.5028.920.5%0.1%Tech
601138
CN¥53.80-14.4%55.4%CN¥1.1tCN¥90.4326.330.4%1.8%Tech
ENR
€146.16-2.9%43.3%€124.8b€199.0856.226.3%0.5%Capital Goods
2308
NT$1,530.00-18.6%169.8%NT$4.0tNT$2,665.3548.729.7%0.8%Tech
6098
JP¥12,915.004.5%42.7%JP¥17.9tJP¥13,018.7536.113.6%0.2%Commercial Services
MELI
US$1,885.734.8%-20.6%US$94.5bUS$2,214.8849.826.7%0%Retail
VRT
New
US$227.50-25.2%56.3%US$85.7bUS$349.0050.525.2%0.1%Capital Goods
6981
New
JP¥6,416.00-24.9%183.0%JP¥11.7tJP¥11,035.2949.924.4%1.1%Tech
4519
JP¥7,071.00-2.0%-3.9%JP¥11.6tJP¥9,686.6724.712.2%1.9%Pharmaceuticals & Biotech
SE
US$106.246.8%-32.2%US$66.4bUS$142.2640.624.0%n/aRetail
HO
€243.302.1%3.2%€50.0b€292.6733.416.3%1.6%Capital Goods
FIX
US$1,697.84-7.3%141.4%US$53.4bUS$2,210.8641.620.8%0.2%Capital Goods
GALD
CHF 180.656.7%41.7%CHF 42.4bCHF 191.9485.924.3%0.2%Pharmaceuticals & Biotech
FITB
US$56.59-1.0%36.1%US$51.3bUS$62.801.622.2%2.8%Banks
BE
New
US$207.12-4.7%453.9%US$48.2bUS$273.51249.042.5%n/aCapital Goods
CIEN
US$372.07-8.7%300.8%US$46.8bUS$565.71120.230.4%n/aTech
COHR
New
US$249.06-20.5%131.5%US$43.4bUS$391.45121.647.5%n/aTech
2259
New
HK$118.20-1.1%n/aHK$316.3bHK$200.2018.018.2%1.3%Materials
CLS
New
CA$493.324.8%78.1%CA$53.1bCA$682.9636.332.4%n/aTech
FLEX
US$111.91-12.5%124.4%US$37.7bUS$160.5042.144.9%n/aTech
Page 1 of 8